-
Mashup Score: 4
AbstractBackground and Aims. Since the introduction of direct oral anticoagulant (DOAC) for atrial fibrillation (AF) therapy, inappropriate and/or underdosing o
Source: academic.oup.comCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 4
AbstractBackground and Aims. Since the introduction of direct oral anticoagulant (DOAC) for atrial fibrillation (AF) therapy, inappropriate and/or underdosing o
Source: academic.oup.comCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 6Effectiveness and Safety of Anticoagulation Therapy in Frail Patients With Atrial Fibrillation - 8 month(s) ago
Background: Frail patients with atrial fibrillation (AF) are less likely to receive anticoagulation than nonfrail patients with AF despite frailty being associated with poorer clinical outcomes inclu
Source: www.ahajournals.orgCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 8Coagulation Biomarkers and Clinical Outcomes in Elderly Patients With Nonvalvular Atrial Fibrillation: ANAFIE Subcohort Study - 8 month(s) ago
Abstract Background Little is known about the relationship between coagulation biomarkers and clinical outcomes in patients with atrial fibrillation (AF) treated with anticoagulants, especially dir…
Source: www.jacc.orgCategories: Latest Headlines, Partners & KOLsTweet-
Results from an ANAFIE Registry sub-cohort study of elderly nonvalvular #AFib pts show an assoc. between ⬆️ levels of coagulation biomarkers with an ⬆️ risk of major 🩸, mortality, & non-stroke/systemic embolic #CVD events. https://t.co/5U5qjrE3LI #JACCAsia #DOAC #CardioTwitter https://t.co/MX9nSXrzUC
-
-
Mashup Score: 5
Richard A. and Susan F. Smith Center for Outcomes Research in Cardiology, Division of Cardiology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA; Heart and Vascular Center, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA Thrombosis Research Institute, London, United Kingdom Faculty of Pharmacy, University of Montreal, Montreal, Quebec, Canada
Source: www.ahajournals.orgCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 0Comparison of phenprocoumon with direct oral anticoagulants in catheter ablation of atrial fibrillation - 9 month(s) ago
AbstractAims. In patients undergoing catheter ablation for atrial fibrillation (AF), direct oral anticoagulants (DOACs) are as effective and safe as the vitamin
Source: academic.oup.comCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 0DOAC Management Strategies and Clinical Outcomes for Adults With Atrial Fibrillation - 10 month(s) ago
This cohort study compares outcomes associated with 3 direct oral anticoagulant care (DOAC) models for preventing adverse anticoagulation-related outcomes among patients with atrial fibrillation.
Source: jamanetwork.comCategories: General Medicine Journals and Societies, Latest HeadlinesTweet
-
Mashup Score: 2Risk of Bleeding in Liver Cirrhosis Receiving Direct Oral Anticoagulants: A Systematic Review and Meta-analysis - 10 month(s) ago
Thieme E-Books & E-Journals
Source: www.thieme-connect.deCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0Association of Alternative Anticoagulation Strategies and Outcomes in Patients With Ischemic Stroke While Taking a Direct Oral Anticoagulant - 11 month(s) ago
Background and Objectives: Ischemic stroke despite direct oral anticoagulant (DOAC) is increasingly common and portends high risk of subsequent ischemic stroke. Efficacy and safety of antithrombotic regimens following the condition are unclear. We aimed to compare the outcomes of patients with ischemic stroke despite DOAC with and without an alternative antithrombotic regimen, and determine the…
Source: NeurologyCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 4Updated Renal Dosage Recommendations for Rivaroxaban in Patients Experiencing or at Risk of Thromboembolic Disease - American Journal of Cardiovascular Drugs - 11 month(s) ago
Patients with chronic kidney disease are at an increased risk of venous thromboembolism (VTE). The factor Xa inhibitor rivaroxaban has been shown to provide similar efficacy and a lower risk of bleeding compared with vitamin K antagonists for the treatment and prevention of VTE. Rivaroxaban has been studied in patients with varying degrees of renal impairment, and this review summarizes current…
Source: SpringerLinkCategories: Cardiologists, Latest HeadlinesTweet
Characteristics of patients with #AF and #DOAC inappropriate dosing 👉 https://t.co/2aC5ycHivI @EuropaceEiC @GiulioConte9 @Dominik_Linz @FraSantoroMD @AndyZhangMD @marcovitoloMD @MBergonti #Europace #arrhythmias https://t.co/3EyJu5yk8e